Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

202085 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifiers, NCT02558400 and NCT02674854.

Good health and well-being

Published in: Advances in Therapy

Volume 37, Issue 4, pp. 1620-1631

Field-Weighted Citation Impact: 8.74